The trajectory of companies tied to Viagra's legacy presents a complex investment picture . While the initial success generated substantial returns , generic competition have significantly diminished sales . Investing in connected pharmaceutical businesses now requires a discerning assessment of patent rights , evolving healthcare changes, and the